Author:
Emi Manabu,Kim Ryungsa,Tanabe Kazuaki,Uchida Yoko,Toge Tetsuya
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Huang Z: Bcl-2 family proteins as targets for anticancer drug design. Oncogene. 2000, 19: 6627-6631. 10.1038/sj.onc.1204087.
2. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T: Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol. 2002, 50: 343-352. 10.1007/s00280-002-0522-7.
3. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med. 2003, 7: 249-257.
4. Verrier F, Deniaud A, Lebras M, Metivier D, Kroemer G, Mignotte B, Jan G, Brenner C: Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene. 2004, 23: 8049-8064. 10.1038/sj.onc.1208001.
5. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 1994, 54: 5501-5507.
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献